Just released: Part 2 with DELFI Diagnostics CEO @susantousi on the Geonomics Podcast discussing how our advanced genomic technology is revolutionizing lung cancer screening with 75% stage I sensitivity. From engineering to biotech leadership – Susan charts DELFI's vision for

How are leading health systems implementing AI-powered blood testing for #lungcancerscreening? Find out at the @BeckersHR webinar on March 18 when leaders from @OSFHealthCare and @AHNtoday share their @FirstLookLung implementation strategies. Register:

Nicholas Dracopoli, PhD, CSO at DELFI, will be speaking at #TRICON2025 tomorrow, March 12 about DELFI-TF, a tumor-agnostic, mutation-independent WGS test for treatment response monitoring and clinical outcome prediction. If you're attending, don't miss this session:

DELFI CEO @susantousi will be featured in a Plenary Keynote Session at #TRICON2025 tomorrow, March 11 at 4:15 PM PT in San Diego. The panel will explore how innovative companies are pushing the boundaries of precision medicine. Don't miss this discussion! Learn more:

Join our @BeckersHR webinar on March 18 to learn how healthcare system leaders from @OSFHealthCare and @AHNtoday are implementing DELFI’s @FirstLookLung test for lung cancer screening in their organizations. Register: https://t.co/yEFNqQNqkX

Lung cancer claims over 127,000 lives annually in the U.S. Early detection aided by tools like FirstLook Lung can help health systems prevent the worst effects of lung cancer. This #NationalCancerPreventionMonth, let’s prioritize lung health. Learn more: https://t.co/Aia5cJZC28

DELFI is proud to endorse the Lung Cancer Screening and Prevention Act (H.R. 1406), introduced to Congress this week by Representative @VernBuchanan. The bill aims to expedite CMS coverage authority for FDA-approved/cleared #lungcancerscreening tests. https://t.co/HujP9i9giE

DELFI CEO @susantousi joins @TheralDTimpson on @mendelspod to discuss how our next-gen #liquidbiopsy technology makes #lungcancer screening more accessible and shows promise in other cancer types and treatment monitoring. Listen here:

Big day for DELFI at #PMWC25 tomorrow! Dr. Victor Velculescu receives the Pioneer Award and delivers his keynote at 9:00 a.m. PT. Later, @peterbachmd chairs a panel on multi-cancer early detection at 3:30 p.m. PT. Full program: https://t.co/Pur54cl2ai

"At DELFI Diagnostics, we're focused on addressing the global burden of late-stage cancer diagnosis." — Dr. Lindsey Cotton On #WorldCancerDay, we recognize the need for accessible screening, particularly for #lungcancer, the leading cause of cancer death globally.

DELFI Founder Dr. Victor Velculescu will be honored with the Pioneer Award at #PMWC25! Listen to his keynote, “Early Detection of Cancer Using Cell-free DNA Fragmentomes.” Feb 6, 9 am PT | Silicon Valley https://t.co/Pur54cl2ai #CancerResearch #Fragmentomics

Watch this Channel 11 @WPXI segment featuring Dr. James Solava, PCP at @AHNtoday, explaining how the @FirstLookLung blood test makes the process of starting lung cancer screening easier and Mary Knight, an AHN patient, who describes her experience receiving the test.

Big strides have been made with #lungcancer screening in recent decades, thanks to advancements in science & technology. #LDCT, #AI, #machinelearning & #NGS are transforming early detection. Learn about DELFI’s blood-based @FirstLookLung test: https://t.co/KINgbOYpow

We’re committed to advancing #healthequity by making #cancerscreening accessible. Honoring Dr. King’s legacy means addressing disparities and striving for a future where everyone has access to life-saving technologies. Learn more: https://t.co/QA3oU9Npb8 #MLKDay

Attending the 43rd Annual @jpmorgan Healthcare Conference? Don’t miss our CEO @susantousi's presentation and Q&A session today at 7:30am PT.

A great new piece in @oronline highlights DELFI’s collaboration with @AHNtoday to offer the @FirstLookLung blood test through their primary care, pulmonology, and community-based cancer screening clinics to increase #lungcancerscreening rates.

Read @DeciBio's Women of Precision Medicine: 25 Perspectives for 2025, featuring DELFI CEO @susantousi and 24 other women leaders driving significant advances in #precisionmedicine.

Listen to Dr. Ali Zaidi from @AHNtoday on the Medical Frontiers podcast as he discusses advances in #liquidbiopsy tech for #cancerscreening, including DELFI’s @FirstLookLung blood test, which is available to eligible patients at AHN clinics and screening events.

DELFI is pleased to announce that we will speak at the upcoming 43rd Annual @jpmorgan Healthcare Conference next week. Our CEO @Susantousi is scheduled to present on Thursday, January 16, 2025 at 7:30am PT. Read more: https://t.co/vtNIPNIUZC #JPM2025

As we welcome 2025, we'd like to recognize DELFI's incredible team, our valued partners, collaborators and community of supporters. Your tireless efforts in #cancerdetection meaningfully improve patient outcomes. Here's to a bright, healthy #NewYears2025 🎆